MATERIALS

AND METHODS
Patients and treatment.
The patients and method of study were reported previously.' In brief, 1 1 1 consecutive adults, aged 17 to 50 years, with newly diagnosed untreated ANL were registered on study from May 1977 to July 1982. Following registration, patients were begun on induction chemotherapy.
Patients failing to achieve a complete remission after two cycles of induction chemotherapy were taken off study. Those achieving a complete remission were HLAtyped along with their family members.
If an HLA-identical sibling was found, the patient was offered marrow transplantation.
Patients without HLA-identical siblings and those who were offered but who refused transplantation were treated with two cycles of consolidation chemotherapy and then randomized to either intensification alone at 6 and 1 2 months or both intensification plus low-dose maintenance therapy given monthly. The chemotherapy treatment schedule is presented in Table I . Marrow transplantation followed preparation with cyclophosphamide and total body irradiation as described.'
The endpoints used were (a) the first occurrence of relapse or death and, (b) death. The time-to-event curves were estimated by the product limit (or Kaplan-Meier)2 method, and two test statistics were evaluated. Fig 1A and B, the 86 patients were considered as three groups. In  Fig 2A and B, the patients were divided according to "protocol intent."
In Fig 3A and B, they were divided according to actual treatment received.
The results of the various group comparisons are shown in 
